Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-08Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-06Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-03Chronic Fatigue in Multiple Sclerosis: Validating Clinical Performance, Economic, and Organizational Benefits of MSCopilot Boost Compared to Standard Care
-
CLINICAL_TRIALS study record update · 2025-10-03The M2M LEADERS Project: Lakeshore Examination of Activity, Disability, and Exercise Response Study (LEADERS)
-
CLINICAL_TRIALS study record update · 2025-10-02Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-02Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-02MS-FLOWER: MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience
-
CLINICAL_TRIALS study record update · 2025-10-02Examination of the Relationship Between Mechanical Properties of Respiratory and Lower Extremity Muscles, Respiratory Function, Fatigue, and Anxiety-Depression in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-01Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
-
CLINICAL_TRIALS study record update · 2025-09-30A Phase 2, Double-blind, Randomized, Placebo-controlled Study Assessing Efficacy and Safety of SAR441344, a CD40L-antagonist Monoclonal Antibody, in Participants With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-30Serum Neurofilaments Light Chain and GFAP (Glial Fibrillary Acidic Protein) in Atypical Idiopathic Inflammatory Demyelinating Disorders
-
CLINICAL_TRIALS study record update · 2025-09-29Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-26Sexual Dysfunction Prevalence and Its Relationship With Various Factors in Women With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-25To Evaluate the Activity and the Efficacy of Traditional Swallowing Therapy (TST) Plus Neuromuscular Electrostimulation (NMES) vs TST Plus Sham- NMES in Multiple Sclerosis People With Dysphagia
-
CLINICAL_TRIALS study record update · 2025-09-24A Crossover Study Evaluating the Impact of the Cionic Neural Sleeve on Mobility, Disability, Fall Risk, and Physical Activity in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-24Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
-
CLINICAL_TRIALS study record update · 2025-09-23Truly Portable MRI for Extremity and Brain Imaging Anywhere & Everywhere
-
CLINICAL_TRIALS study record update · 2025-09-23The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-09-23An Open-label Study of Excretion Balance and Pharmacokinetics Following a Single Oral Dose of [14C]-SAR442168 (Not More Than 3.7 MBq) in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2025-09-22Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2025-09-22Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-22Promotion of Exercise Behavior Among Rural-Residing African-Americans With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-22The Application of the L Test's Validity and Reliability in Single and Dual Task Conditions in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-19Telerehabilitation for Multiple Sclerosis: Artificial Intelligence vs. Conventional Approaches in Strength Training. A Sin-gle-Blinded Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-09-19Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation (MS-PEKOS)